Delivery Order SPE2DB22D2206-SPE2DB25FJC13
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $14,373.49 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $8,910.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $11,525.99 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $38,550.86 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-unit packaging) with an ultimate completion date of August 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. TRIUMEQ is a prescription antiretroviral medication used in HIV treatment, indicating this delivery supports federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $24,294.69 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packages) on September 17, 2025, with a completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a fixed-dose combination antiretroviral medication used in the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,675.06 firm fixed-price delivery order for TRIUMEQ 600-50-300 mg tablets (30-unit pack) to be delivered to Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA Troop Support Medical. TRIUMEQ is an antiretroviral combination medication used in HIV...
- The Defense Logistics Agency awarded a $11,096.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The delivery will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $12,117.72, represents a firm fixed price contract with no set-aside designation, reflecting a competitively awarded transaction under open procurement standards. The contract is scheduled for ultimate completion on August 8, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10.87K delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a firm fixed price arrangement. The award, issued on May 30, 2025, represents a competitive, non-set-aside procurement with an ultimate completion date of June 2, 2025. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, consistent with AmerisourceBergen's broader role as a critical pharmaceutical supplier to the federal...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC13Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp holds significant capacity to supply brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The delivery order structure allows the Defense Logistics Agency to fulfill specific pharmaceutical requirements efficiently while leveraging the stability and pricing benefits of the underlying indefinite delivery contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 7/25/25 |